V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210032664 | 210008724 | 1.67 | 65 | Curative (C) | 2015-12-27 | 2016-04-27 | UKALL14- Intens/CNS Proph | N | N | 210016247 | UKALL2014 |
| 210032665 | 210008729 | 1.76 | 86.2 | Curative (C) | 2017-01-16 | 2018-01-12 | UKALL14- Ph 2 Induction | Y | N | 210016258 | UKALL2014 |
| 210032666 | 210008735 | 1.65 | 0 | null | 2017-02-02 | 2017-09-15 | UKALL14- Intens/CNS Proph | y | N | 210016266 | UKALL2014 |
| 210032667 | 210008742 | 1.88 | 87 | Curative (C) | 2016-10-17 | 2016-10-26 | UKALL14- Ph 1 Induction | Y | N | 210016281 | UKALL2014 |
| 210032668 | 210008748 | 1.78 | 52 | Curative (C) | 2014-09-04 | 2014-11-11 | UKALL14- Ph 2 Induction | 02 | N | 210016287 | UKALL2014 |
| 210032669 | 210019533 | 1.62 | 73.6 | Curative (C) | 2014-08-07 | 2014-08-15 | UKALL14- Ph 2 Induction | N | N | 210016296 | UKALL2014 |
| 210032670 | 210034881 | 1.71 | 85 | Curative (C) | 2013-09-01 | 2013-12-10 | UKALL14- Ph 2 Induction | N | N | 210016307 | UKALL2014 |
| 210032671 | 210008754 | null | 95.799 | Curative (C) | 2012-08-16 | 2013-05-20 | UKALL14- Maintenance | N | null | 210016308 | UKALL2014 |
| 210032672 | 210008760 | 1.61 | 60.9 | Curative (C) | 2017-07-14 | 2018-04-21 | UKALL14- Ph 2 Induction | N | null | 210016323 | UKALL2014 |
| 210032673 | 210008764 | 1.87 | null | Curative (C) | 2017-04-23 | 2017-08-04 | UKALL14- Ph 2 Induction + Imatinib | Y | null | 210016332 | UKALL2014 |
| 210032674 | 210008771 | 1.73 | 138 | Curative (C) | 2014-05-10 | 2014-05-10 | UKALL14- Intens/CNS Proph | null | N | 210016336 | UKALL2014 |
| 210032675 | 210008776 | 1.75 | 62.1 | Curative (C) | 2016-07-26 | 2016-07-26 | UKALL14- Ph 2 Induction | Y | N | 210016344 | UKALL2014 |
| 210032676 | 210008780 | 1.68 | 97.8 | Curative (C) | 2014-10-14 | 2015-01-14 | UKALL14- Cons Cycle 2 | N | N | 210016347 | UKALL2014 |
| 210032677 | 210008782 | 1.67 | null | Curative (C) | 2017-08-05 | 2017-12-01 | UKALL 14 TRIAL | 1 | N | 210016352 | UKALL2014 |
| 210032678 | 210008784 | 1.52 | 83 | Curative (C) | 2015-11-22 | 2016-08-20 | UKALL14- Cons Cycle 1 | Y | N | 210016365 | UKALL2014 |
| 210032679 | 210008787 | null | 60.5 | Curative (C) | 2016-01-21 | 2016-10-26 | UKALL14- Intens/CNS Proph | Y | null | 210016374 | UKALL2014 |
| 210032680 | 210008793 | null | 70.1 | Curative (C) | 2015-04-07 | 2015-04-07 | UKALL14- Maintenance | Y | N | 210016377 | UKALL2014 |
| 210032681 | 210008802 | 1.56 | 85 | Adjuvant (A) | 2018-02-08 | 2018-03-19 | UKALL14- Cons Cycle 1 | Y | N | 210016410 | UKALL2014 |
| 210032682 | 210026474 | 1.93 | 103 | Curative (C) | 2014-07-26 | 2015-02-28 | UKALL 14 TRIAL | N | N | 210016427 | UKALL2014 |
| 210032683 | 210036018 | null | 115.3 | Curative (C) | null | 2014-01-06 | UKALL14- Maintenance | N | null | 210016429 | UKALL2014 |
| 210032684 | 210008806 | 1.6 | 84.9 | Curative (C) | 2018-03-20 | 2018-09-09 | UKALL 14 TRIAL | Y | N | 210016434 | UKALL2014 |
| 210032685 | 210008810 | 1.69 | 70.1 | Curative (C) | null | 2017-09-16 | UKALL14- Cons Cycle 2 | Y | N | 210016439 | UKALL2014 |
| 210032686 | 210026475 | 1.72 | 86.8 | Curative (C) | 2016-10-11 | 2016-11-11 | UKALL14- Intens/CNS Proph | Y | N | 210016439 | UKALL2014 |
| 210032687 | 210038129 | 1.74 | 70 | Curative (C) | 2015-12-30 | 2016-10-20 | UKALL14- Cons Cycle 2 | N | N | 210016457 | UKALL2014 |
| 210032688 | 210008817 | 1.78 | 143.5 | Curative (C) | 2013-02-22 | 2015-04-29 | UKALL 14 TRIAL | N | N | 210016482 | UKALL2014 |
| 210032689 | 210008821 | null | 75 | Curative (C) | 2017-03-09 | 2017-07-03 | UKALL14- Ph 2 Induction + Imatinib | N | null | 210016503 | UKALL2014 |
| 210032690 | 210008826 | 1.9 | 106.499 | Curative (C) | 2017-02-05 | 2017-04-12 | UKALL14- Intens/CNS Proph | Y | N | 210016514 | UKALL2014 |
| 210032691 | 210008831 | 1.64 | 61 | Curative (C) | 2014-08-02 | 2014-08-02 | UKALL14- Maintenance | Y | N | 210016535 | UKALL2014 |
| 210032692 | 210008832 | 1.85 | 85.7 | Curative (C) | 2017-03-01 | 2017-09-22 | UKALL14- Cons Cycle 1 | N | N | 210016537 | UKALL2014 |
| 210032693 | 210008835 | 1.76 | 67.1 | Curative (C) | 2016-10-03 | 2016-10-03 | UKALL14- Cons Cycle 2 | Y | null | 210016538 | UKALL2014 |
| 210032694 | 210008836 | 1.75 | 62 | Curative (C) | 2017-09-09 | 2017-10-01 | UKALL14- Cons Cycle 1 | 01 | null | 210016577 | UKALL2014 |
| 210032695 | 210008837 | null | 68.7 | Curative (C) | 2013-11-29 | 2013-11-29 | UKALL14- Cons Cycle 2 | 02 | N | 210016582 | UKALL2014 |
| 210032696 | 210008838 | 1.65 | 45 | Curative (C) | 2015-09-30 | 2015-10-03 | UKALL 14 TRIAL | Y | null | 210016587 | UKALL2014 |
| 210032697 | 210019588 | 1.93 | 84.9 | Curative (C) | 2018-01-02 | 2018-04-10 | UKALL14- Intens/CNS Proph | 2 | N | 210016593 | UKALL2014 |
| 210032698 | 210008843 | 1.78 | 74.9 | Curative (C) | 2013-01-12 | 2013-09-21 | UKALL14- Maintenance | 01 | N | 210016611 | UKALL2014 |
| 210032699 | 210008849 | 1.65 | 58.8 | Curative (C) | 2013-08-02 | 2013-12-01 | UKALL14- Cons Cycle 1 | N | N | 210016625 | UKALL2014 |
| 210032700 | 210019595 | 1.67 | 69 | Curative (C) | 2014-04-29 | 2014-10-16 | UKALL14- Cons Cycle 3 | Y | N | 210016637 | UKALL2014 |
| 210032701 | 210008854 | 1.82 | 69.1 | Curative (C) | 2017-07-06 | 2017-12-10 | UKALL14- Cons Cycle 1 | 02 | N | 210016650 | UKALL2014 |
| 210032702 | 210008862 | 1.88 | 87.5 | Curative (C) | 2018-09-03 | 2018-09-03 | UKALL14- Cons Cycle 1 | Y | null | 210016706 | UKALL2014 |
| 210032703 | 210008864 | 1.74 | 93.4 | Curative (C) | 2016-05-15 | 2017-03-14 | UKALL14- Cons Cycle 2 | N | N | 210016712 | UKALL2014 |
| 210032705 | 210019604 | 1.84 | 65 | Curative (C) | 2014-04-11 | 2014-09-18 | UKALL14- Ph 1 Induction | 1 | N | 210016751 | UKALL2014 |
| 210032706 | 210008873 | 1.89 | 75 | Curative (C) | 2017-12-13 | 2018-12-17 | UKALL14- Cons Cycle 3 | N | N | 210016759 | UKALL2014 |
| 210032707 | 210008876 | 1.8 | 89.7 | Curative (C) | 2017-02-21 | 2017-11-14 | UKALL14- Cons Cycle 2 | N | N | 210016766 | UKALL2014 |
| 210032708 | 210026497 | 1.6 | 74 | Curative (C) | 2016-02-23 | 2016-10-11 | UKALL 14 TRIAL | N | null | 210016773 | UKALL2014 |
| 210032709 | 210008881 | 1.64 | 82 | Curative (C) | 2014-08-24 | 2015-04-26 | UKALL14- FMC (1 day) Conditioning | 01 | N | 210016782 | UKALL2014 |
| 210032710 | 210008885 | 1.75 | 63 | Curative (C) | 2014-07-21 | 2015-01-06 | UKALL 14 TRIAL | Y | N | 210016786 | UKALL2014 |
| 210032711 | 210008887 | null | 80 | Disease modification (D) | null | 2017-09-20 | UKALL14- Maintenance | Y | N | 210016787 | UKALL2014 |
| 210032712 | 210008890 | 1.72 | 75.2 | Curative (C) | 2015-10-23 | 2015-10-27 | UKALL14- Cons Cycle 3 | null | null | 210016794 | UKALL2014 |
| 210032713 | 210008892 | 1.72 | 106.5 | Curative (C) | 2015-03-25 | 2017-01-07 | UKALL14- Ph 1 Induction | 01 | null | 210016826 | UKALL2014 |
| 210032714 | 210008895 | 1.72 | 70.1 | Curative (C) | 2014-11-21 | 2015-09-10 | UKALL14- Cons Cycle 3 | 01 | N | 210016838 | UKALL2014 |